Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Randomised, placebo controlled study of the effect of sildenafil on hypoxia-induced pulmonary hypertension
Source of recordUK Trials
ISRCTNISRCTN41186152
Date ISRCTN assigned08/03/2002
Local reference number(s)PG/02/024
Public titleRandomised, placebo controlled study of the effect of sildenafil on hypoxia-induced pulmonary hypertension
Scientific title
AcronymN/A
Disease/condition/study domainHypoxia-induced pulmonary hypertension
Study hypothesisNot provided at time of registration
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Males or females aged 18 years and over
2. Resting pulmonary artery pressure ≥25 mmHg
3. Written informed consent must be obtained by the investigator before the subject is screened for the study
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsPatients are randomised to:
1. Placebo tds for 3 months
2. Sildenafil 25 mg tds for 3 months, or
3. Sildenafil 100 mg tds for 3 months
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingBritish Heart Foundation
Sponsor nameBritish Heart Foundation (UK)
Sponsor details14 Fitzhardinge Street
London
United Kingdom
W1H 6DH
Sponsor telephone+44 (0)20 7935 0185
Sponsor fax+44 (0)20 7486 5820
Sponsor emailresearch@bhf.org.uk
Sponsor websitehttp://www.bhf.org.uk/
Contact nameProfessor MR Wilkins
Contact detailsSection on Clinical Pharmacology
Imperial College
Hammersmith Hospital
Du Cane Road
London
United Kingdom
W12 0NN
Contact telephone+44 (0)20 8383 2049
Contact fax+44 (0)20 8383 2066
Contact emailm.wilkins@ic.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN41186152
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central